Inappropriate polypharmacy: Reducing the burden of multiple medication

Clinical Medicine, Journal of the Royal College of Physicians of London

Volumn 7, Issue 5, 2007, Pages 514-517

  Milton, James C ^a   Jackson, Stephen H D ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMORBIDITY; HEALTH CARE ACCESS; HEALTH SERVICE; MEDICAL PRACTICE; MEDICAL RESEARCH; PATIENT COMPLIANCE; PATIENT COUNSELING; POLYPHARMACY; REVIEW; RISK ASSESSMENT;

EID: 35748946027     PISSN: 14702118     EISSN: None     Source Type: Journal    
DOI: 10.7861/clinmedicine.7-5-514     Document Type: Review

References (20)

1. Department of Health. Prescriptions dispensed in the community for 1993 to 2003, England. London: DH, 2004.
2. National Statistics Office. www.statistics.gov.uk
3. Donnelly T, Jackson SH. Therapeutics. In: Rai GS, Mulley GP (eds). Elderly medicine: a training guide, 2nd edn. London: Churchill Livingstone, Ch 21 (in press).
4. Rollason V, Vogt N. Reduction of polypharmacy in the elderly: a systematic review of the role of the pharmacist. Drugs Aging 2003;20:817-32.
5. Department of Health. Medicines and older people: implementing medicines-related aspects of the NSF for Older People. London: DH, 2001.
6. National Audit Office. Prescribing costs in primary care. London: NAO, 2007.
7. Mangoni AA, Jackson SH. The implications of a growing evidence base for drug use in elderly patients. Part 1. Statins for primary and secondary cardiovascular prevention. Review. Br J Clin Pharmacol 2006;61:494-501.
8. Mangoni AA, Jackson SH. The implications of a growing evidence base for drug use in elderly patients. Part 2. ACE inhibitors and angiotensin receptor blockers in heart failure and high cardiovascular risk patients. Review. Br J Clin Pharmacol 2006;61:502-12.
9. Mangoni AA, Jackson SH. The implications of a growing evidence base for drug use in elderly patients. Part 3. Beta-adrenoceptor blockers in heart failure and thrombolytics in acute myocardial infarction. Review. Br J Clin Pharmacol 2006;61:513-20.
10. Dhesi JK, Allain TJ, Mangoni AA, Jackson SH. The implications of a growing evidence base for drug use in elderly patients. Part 4. Vitamin D and bisphosphonates for fractures and osteoporosis. Review. Br J Clin Pharmacol 2006;61:521-8.
11. Green JL, Hawley JN, Rask KJ. Is the number of prescribing physicians an independent risk factor for adverse drug events in an elderly outpatient population? Am J Geriatr Pharmacother 2007;5:31-9.
12. Lindley CM, Tully MP, Paramsothy V, Tallis RC. Inappropriate medication is a major cause of adverse drug reactions in elderly patients. Age Ageing 1992;21:294-300.
13. Campbell SE, Seymour DG, Primrose WR; ACMEPLUS Project. A systematic literature review of factors affecting outcome in older medical patients admitted to hospital. Review. Age Ageing 2004;33:110-5.
14. Frazier SC. Health outcomes and polypharmacy in elderly individuals: an integrated literature review. J Gerontol Nurs 2005;31:4-11.
15. Ziere G, Dieleman JP, Hofman A et al. Polypharmacy and falls in the middle age and elderly population. Br J Clin Pharmacol 2006;61:218-23.
16. Campbell AJ, Robertson MC, Gardner MM, Norton RN, Buchner DM. Psychotropic medication withdrawal and a home-based exercise program to prevent falls: a randomized, controlled trial. J Am Geriatr Soc 1999;47:850-3.
17. Chumney EC, Robinson LC. The effects of pharmacist interventions on patients with polypharmacy. Pharmacy Practice 2006;4:103-9.
18. Williams B, Pointer NR, Brown MJ et al. British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary. BMJ 2004;328:634-40.
19. Chong SA, Ravichandran N, Poon LY, Soo KL, Verma S. Reducing polypharmacy through the introduction of a treatment algorithm: use of a treatment algorithm on the impact on polypharmacy. Ann Acad Med Singapore 2006;35:457-60.
20. Oborne CA, Batty GM, Maskrey V, Swift CG, Jackson SHD. Development of prescribing indicators for elderly medical patients. Br J Clin Pharmacol 1997;43:91-7.